Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Children's Hospital of Philadelphia offers treatment of H. influenzae for licensing

Nov. 26, 1996

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

Nyotran progresses towards market introduction

Nov. 25, 1996

New class of antibacterial agents discovered by Zeneca

Nov. 25, 1996

Merck & Co. cephalosporins active against MRSA, MRCNS

Nov. 25, 1996

New carbapenems from Takeda

Nov. 22, 1996

Otsuka describes novel cephems

Nov. 22, 1996

Antimalarial combination demonstrates excellent efficacy

Nov. 21, 1996

Pharmagenesis and Lilly collaborate on development of antifungal agents

Nov. 21, 1996

Xylitol chewing gum effective in preventing otitis media

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...